Analyst Ratings for Bio-Rad Labs (BIO)
BIO Rating Summary
BIO Price Target Summary
- Highest: $325.00 (UBS)
- Lowest: $290.00 (Wells Fargo)
- Average: $308.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$308.75 (+5.3%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Avg. $ Target:
$308.75 (+5.3%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/14/2026 | RBC Capital | Dan Leonard | New Coverage | Outperform (N/A) |
320.00 (N/A) |
243.51 (293.17) |
20.39% | Details |
| 4/7/2026 | Citi | Patrick Donnelly | Downgrade | Neutral (Buy) |
300.00 (375.00) |
278.85 (293.17) |
5.14% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
